|
|
||||||||


*
Max-Planck-Institut für Neurobiologie, Martinsried, Germany;
Roche AG, Basel, Switzerland;
CBM, Universidad Autónoma, Cantoblanco, Madrid, Spain; and
§
Unité Mixte de Recherche, Centre National de la Recherche Scientifique 7624, University of Paris, Paris, France
We explored mechanisms involved in B cell self-tolerance against
brain autoantigens in a double-transgenic mouse model carrying the Ig
H-chain (introduced by gene replacement) and/or the L-chain
(conventional transgenic) of the mAb 8.18C5, specific for the myelin
oligodendrocyte glycoprotein (MOG). Previously, we demonstrated that B
cells expressing solely the MOG-specific Ig H-chain differentiate
without tolerogenic censure. We show now that double-transgenic
(TH
mog) B cells expressing transgenic Ig H- and L-chains
are subjected to receptor editing. We show that in adult mice carrying
both MOG-specific Ig H- and L-chains, the frequency of MOG-binding B
cells is not higher than in mice expressing solely the transgenic Ig
H-chain. In fact, in TH
mog double-transgenic mice, the
transgenic
mog L-chain was commonly replaced by
endogenous L-chains, i.e., by receptor editing. In
rearrangement-deficient RAG-2- mice, differentiation of
TH
mog B cells is blocked at an immature stage (defined
by the B220lowIgMlowIgD-
phenotype), reflecting interaction of the autoreactive B cells with a
local self-determinant. The tolerogenic structure in the bone marrow is
not classical MOG, because back-crossing TH
mog mice into
a MOG-deficient genetic background does not lead to an increase in the
proportion of MOG-binding B cells. We propose that an as yet undefined
self-Ag distinct from MOG cross-reacts with the TH
mog B
cell receptor and induces editing of the transgenic
mog
L-chain in early immature B cells without affecting the pathogenic
potential of the remaining MOG-specific B cells. This phenomenon
represents a particular form of chain-specific split
tolerance.
This article has been cited by other articles:
![]() |
C. Breithaupt, B. Schafer, H. Pellkofer, R. Huber, C. Linington, and U. Jacob Demyelinating Myelin Oligodendrocyte Glycoprotein-Specific Autoantibody Response Is Focused on One Dominant Conformational Epitope Region in Rodents J. Immunol., July 15, 2008; 181(2): 1255 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Breithaupt, A. Schubart, H. Zander, A. Skerra, R. Huber, C. Linington, and U. Jacob Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein PNAS, August 5, 2003; 100(16): 9446 - 9451. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bourquin, A. Schubart, S. Tobollik, I. Mather, S. Ogg, R. Liblau, and C. Linington Selective Unresponsiveness to Conformational B Cell Epitopes of the Myelin Oligodendrocyte Glycoprotein in H-2b Mice J. Immunol., July 1, 2003; 171(1): 455 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Picard-Riera, L. Decker, C. Delarasse, K. Goude, B. Nait-Oumesmar, R. Liblau, D. Pham-Dinh, and A. B.-V. Evercooren Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice PNAS, October 1, 2002; 99(20): 13211 - 13216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |